Effect of knee-chest, semi-sitting, and right lateral position on preterm neonates with respiratory distress syndrome

Author(s):  
Ebtsam S. Mahrous ◽  
Amna Aboelmagd
2012 ◽  
Vol 3 (2) ◽  
pp. 218-220
Author(s):  
PANKTI D DESAI ◽  
◽  
HETAL D VORA ◽  
S H MANSURI S H MANSURI

PEDIATRICS ◽  
1984 ◽  
Vol 74 (2) ◽  
pp. 259-264
Author(s):  
William D. Engle ◽  
Billy S. Arant

The possibility that negative potassium balance may occur in critically ill preterm neonates is suggested by factors such as the usual provision of minimal potassium intake, increased plasma aldosterone concentrations, increased prostaglandin synthesis, and the frequent use of diuretic agents. In order to assess the relationship between potassium balance and renal prostaglandins, nine infants with respiratory distress syndrome (mean birth weight 1,264 g, mean gestational age 30.6 weeks) were studied sequentially with timed-urine collections during the first four postnatal days and values were compared with those of 18 preterm infants without respiratory distress syndrome. Mean plasma potassium concentrations decreased significantly from 4.87 ± 0.19 mEq/L (mean ± SEM) on day 1 to 3.83 ± 0.18 mEq/L on day 4, (P < 0.05), and cumulative potassium balance was -4.07 ± 0.95 mEq/kg or 10% of estimated total body potassium. Urinary excretion of prostaglandin E, on day 1 in infants with respiratory distress syndrome was significantly greater than in those without respiratory distress syndrome (22.0 ± 4.9 v 8.3 ± 1.6 ng/mg of creatinine) and varied directly with urinary potassium excretion (r = .66, P < .001). These studies suggest that consideration be given to the importance of providing sufficient potassium to prevent hypokalemia in the stressed preterm infant and that pharmacologic agents that alter prostaglandins or potassium excretion should be used with caution.


2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Vesara Ardhe Gatera ◽  
Rizky Abdulah ◽  
Ida Musfiroh ◽  
Raden Tina Dewi Judistiani ◽  
Budi Setiabudiawan

To update the guidelines regarding vitamin D status in respiratory distress syndrome, we reviewed recent human and animal studies on the benefits of vitamin D in respiratory distress. We searched PubMed and ProQuest for studies on the use of vitamin D from 2009 to 2017. The common parameters in these studies included the use of lung tissue, phospholipids, blood, and plasma to assess the effects of vitamin D on respiratory syndrome. The metabolized form of vitamin D used in these studies was 1,25(OH)2D3 in animal studies and 25(OH)D in human studies. Vitamin D supplementation decreases the risk of respiratory distress syndrome, improves the quality of life, and is relatively effective and safe for preterm neonates as well as during lung maturation. However, although vitamin D supplementation may offer benefits for respiratory distress syndrome, the optimal dosing strategies for specific types of risk factors in the lungs must be clarified to confirm the therapeutic efficacy.


2019 ◽  
Vol 39 (S1) ◽  
pp. 3-12 ◽  
Author(s):  
Kajal Jain ◽  
Sushma Nangia ◽  
Vishnu Bhat Ballambattu ◽  
Venkataseshan Sundaram ◽  
M. Jeeva Sankar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document